74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
74%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Cochlear Ltd
Closed
SectorConsumer cyclical
265.8 -0.04
Overview
Share price change
24h
Min
265.45
Max
266.28
Income | 40M 205M |
|---|---|
Sales | 35M 1.2B |
P/E Sector Avg | 46.127 30.203 |
EPS | 2.963 |
Dividend yield | 1.65 |
Profit margin | 17.503 |
Employees | 4,996 |
EBITDA | 17M 316M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +10.94% upside |
Dividend yield Sector Avg | 1.65% 3.57% |
|---|
Market Cap | -3.9B 17B |
|---|---|
Previous open | 265.84 |
Previous close | 265.8 |
Cochlear Ltd Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Cochlear Ltd Forecast
Price Target
By TipRanks
10.94% upside
12 Months Forecast
Average 288.689 AUD 10.94%
High 312 AUD
Low 264.71 AUD
Based on 13 Wall Street analysts offering 12 month price targets forCochlear Ltd - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Cochlear Ltd
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.
